// “The next potential step for French biotech is to scale up and go global. Asia offers diverse opportunities with Hong Kong the ideal launchpad for French biotech as an engine of funding, partnerships and talent to translate and scale medical innovations to global success.
French biotech domain knowledge and innovation will also be a vital boost to Hong Kong’s ambition to become an international innovation hub,” said Mr Albert Wong, CEO of HKSTP. https://sg.finance.yahoo.com/news/hong-kong-science-park-invites-133000735.html //